BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 31248178)

  • 1. Transcriptomic Insights into the Response of the Olfactory Bulb to Selenium Treatment in a Mouse Model of Alzheimer's Disease.
    Zheng R; Zhang ZH; Zhao YX; Chen C; Jia SZ; Cao XC; Shen LM; Ni JZ; Song GL
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31248178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selenomethionine Ameliorates Neuropathology in the Olfactory Bulb of a Triple Transgenic Mouse Model of Alzheimer's Disease.
    Zhang ZH; Chen C; Wu QY; Zheng R; Chen Y; Liu Q; Ni JZ; Song GL
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27689994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selenium-enriched yeast inhibited β-amyloid production and modulated autophagy in a triple transgenic mouse model of Alzheimer's disease.
    Song GL; Chen C; Wu QY; Zhang ZH; Zheng R; Chen Y; Jia SZ; Ni JZ
    Metallomics; 2018 Aug; 10(8):1107-1115. PubMed ID: 30043821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selenomethionine reduces the deposition of beta-amyloid plaques by modulating β-secretase and enhancing selenoenzymatic activity in a mouse model of Alzheimer's disease.
    Zhang ZH; Chen C; Wu QY; Zheng R; Liu Q; Ni JZ; Hoffmann PR; Song GL
    Metallomics; 2016 Aug; 8(8):782-9. PubMed ID: 27465436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selenomethionine ameliorates cognitive decline, reduces tau hyperphosphorylation, and reverses synaptic deficit in the triple transgenic mouse model of Alzheimer's disease.
    Song G; Zhang Z; Wen L; Chen C; Shi Q; Zhang Y; Ni J; Liu Q
    J Alzheimers Dis; 2014; 41(1):85-99. PubMed ID: 24577479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer's Disease.
    Weissmann R; Hüttenrauch M; Kacprowski T; Bouter Y; Pradier L; Bayer TA; Kuss AW; Wirths O
    J Alzheimers Dis; 2016; 50(2):397-409. PubMed ID: 26639971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
    Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
    J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selenomethionine promoted hippocampal neurogenesis via the PI3K-Akt-GSK3β-Wnt pathway in a mouse model of Alzheimer's disease.
    Zheng R; Zhang ZH; Chen C; Chen Y; Jia SZ; Liu Q; Ni JZ; Song GL
    Biochem Biophys Res Commun; 2017 Mar; 485(1):6-15. PubMed ID: 28109879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology.
    Reale M; D'Angelo C; Costantini E; Di Nicola M; Yarla NS; Kamal MA; Salvador N; Perry G
    J Alzheimers Dis; 2018; 62(1):467-476. PubMed ID: 29439355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of selenomethionine and selenium-enriched yeast in the triple-transgenic mouse model of Alzheimer's disease.
    Zhang ZH; Wu QY; Chen C; Zheng R; Chen Y; Ni JZ; Song GL
    Food Funct; 2018 Jul; 9(7):3965-3973. PubMed ID: 29974078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olfactory deficit is associated with mitral cell dysfunction in the olfactory bulb of P301S tau transgenic mice.
    Li S; Li W; Wu X; Li J; Yang J; Tu C; Ye X; Ling S
    Brain Res Bull; 2019 May; 148():34-45. PubMed ID: 30902575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease.
    Kovács T; Cairns NJ; Lantos PL
    Neuropathol Appl Neurobiol; 1999 Dec; 25(6):481-91. PubMed ID: 10632898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing GABAergic signaling ameliorates aberrant gamma oscillations of olfactory bulb in AD mouse models.
    Chen M; Chen Y; Huo Q; Wang L; Tan S; Misrani A; Jiang J; Chen J; Chen S; Zhang J; Tabassum S; Wang J; Chen X; Long C; Yang L
    Mol Neurodegener; 2021 Mar; 16(1):14. PubMed ID: 33663578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
    Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW
    Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptomic analysis reveals the molecular mechanism of Alzheimer-related neuropathology induced by sevoflurane in mice.
    Ge X; Zhang Y; Zuo Y; Israr M; Li B; Yu P; Gao G; Chang YZ; Shi Z
    J Cell Biochem; 2019 Oct; 120(10):17555-17565. PubMed ID: 31134678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
    Xie Y; Tan Y; Zheng Y; Du X; Liu Q
    J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network-Driven Proteogenomics Unveils an Aging-Related Imbalance in the Olfactory IκBα-NFκB p65 Complex Functionality in Tg2576 Alzheimer's Disease Mouse Model.
    Palomino-Alonso M; Lachén-Montes M; González-Morales A; Ausín K; Pérez-Mediavilla A; Fernández-Irigoyen J; Santamaría E
    Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29077059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA polymerase β decrement triggers death of olfactory bulb cells and impairs olfaction in a mouse model of Alzheimer's disease.
    Misiak M; Vergara Greeno R; Baptiste BA; Sykora P; Liu D; Cordonnier S; Fang EF; Croteau DL; Mattson MP; Bohr VA
    Aging Cell; 2017 Feb; 16(1):162-172. PubMed ID: 27686631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.